[1] S. S. Swain, D. Dude, Anti-dengue medicinal plants: a mini review. Res. Rev. J Pharmacogn Phytochem., 1 (2013) 5-9.
[2] M. E. Beatty, A. Stone, W. D. Fitzsimons, J. N. Hanna, S. K. Lam, S. Vong, Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS. Negl. Trop. Dis., 4 (2010) 890.
[3] Z. Fatima, M. Idrees, M. A. Bajwa, Z. Tahir, O. Ullah, M.Q. Zia, Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan. BMC Microbiol., 11 (2011)200.
[4] E. P. Toepak, U. S. F. Tambunan, In silico design of fragment-based drug targeting host processing α-glucosidase i for dengue fever. Materials Science and Engineering, 172 (2017) 01201.
[5] C. Nitsche, S. Holloway, T. Schirmeister and C. D. Klein, Biochemistry and medicinal chemistry of the dengue virus protease. Chem Rev., 114 (2014) 11348–11381.
[6] A. J. Stevens, M. E. Gahan, S. Mahalingam, P. A. Keller, The medicinal chemistry of dengue fever. J. Med. Chem., 52 (2009) 7911–7926.
[7] S. P. Lim, Q. Y. Wang, C. G. Noble, Y. L. Chen, H. Dong, B. Zou, F. Yokokawa, S. Nilar, P. Smith, D. Beer, J. Lescar, P. Y. Shi, Ten years of dengue drug discovery: Progress and prospects. Antiviral Res., 100 (2013) 500–519.
[8] B. Canard, Antiviral Research and Development against Dengue Virus CDC (2010) The Dengue Update: Dengue Outbreaks Worldwide. Centre for Disease Control and Prevention, 2 (2017) (1.1).
[9] N. M. Nguyen, C. N. Tran, L. K. Phung, K. T. Duong, K. T.; Huynh, Hle. A.;J. Farrar, Q. T. Nguyen, H. T. Tran, C. V. Nguyen, L. Merson, L. T. Hoang, M. L. Hibberd, P. P. Aw, A. Wilm, N. Nagarajan, D. T. Nguyen, M. P. Pham, T. T. Nguyen, H. Javanbakht, K. Klumpp, J. Hammond, R. Petric, M. Wolbers, C. T. Nguyen, C. P. A. Simmons, Randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients, J. Infect. Dis., 207 (2013) 1442-1450.
[10] Bhatt, S.; Gething, P.W.; Brady, O.J.; Messina, J.P.; Farlow, A.W.; Moyes, C.L.; Drake, J.M.;Blanton, R.E., L. K. Silva, V. G. Morato Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population, European Journal of HumanGenetics, vol. 16, no. 6, (2008) 762–765,
[11] M. G. Guzman, G. Kouri, Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987–2007. Transactions of the Royal Society of Tropical Medicine and Hygiene, 102 (6) (2008) 522–523
[12] P. M. Zanotto, E. A. Gould, G. F. Gao, P. H. Harvey, E. C. Holmes, Population dynamics of flaviviruses revealed by molecular phylogenies. Proceedings of the National Academy of Sciences of the United States of America, 93 (2) (1996) 548– 553.
[13] A. S. Ndaghiya, A. I. Ogadimma, S. Sani, Modelling of some Schiff bases as anti-Salmonella typhi drugs: A QSAR approach. Journal of Computational Methods in Molecular Design, 5(4) (2015) 147-157.
[14] S. N. Adawara, P. Mamza, G. A. Shallangwa, I. Abdulkadir. Anti-Dengue potential, Molecular Docking Study of Some Chemical constituents in the leaves of Isatis tinctoria. Chemical Review and Letters, 3(3) (2020) 104-109.
[15] J. C. Madden, M. T. Cronin, Structure-based methods for the prediction of drug metabolism. Expert opinion on drug metabolism & toxicology, 2(4) (2006) 545-557.
[16] Y. C. Martin, Quantitative Drug Design, Marcel Dekker, New York, NY, USA, 1978.
[17] F. Yokokawa, S. Nilar, C. G. Noble, S. P. Lim, R. Rao, S. Tania, G. Wang, G. Lee, J. Hunziker, R. Karuna, U. Manjunatha, Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from a fragment hit using structure-based drug design. J. Medi. Chem., 59(8) (2016) 3935-52.
[18] A. Tropsha, Best practices for QSAR model development, validation, and exploitation. Mol. Inform., 29(6–7) (2010) 476–488.
[19] M. Abdullahi, G. A. Shallangwa, A. Uzairu, In silico QSAR and molecular docking simulation of some novel aryl sulfonamide derivatives as inhibitors of H5N1 influenza A virus subtype. Beni-Suef University Journal of Basic and Applied Sciences, 9(1) (2020) 2.
[20] A. D. Becke, Density‐functional thermochemistry III. The role of exact exchange. J. Chem. Phys., 98 (1993) 5648–5652.
[21] C. Lee, W. Yang, R. G. Parr, Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev., B 37(1988) 785.
[22] A. Schäfer, C. Huber, R. Ahlrichs, Fully optimized contracted Gaussian basis sets of triple zeta valence quality for atoms Li to Kr. J. Chem. Phys., 100 (1994) 5829–5835.
[23] C.W. Yap, PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J. Comput. Chem., 32(7) (2011) 1466–1474.
[24] R.W. Kennard, L.A. Stone, Computer aided design of experiments. Technometrics 11(1) (1969) 137–148.
[25] P. Ambure, R.B. Aher, A. Gajewicz, T. Puzyn, K. Roy, “NanoBRIDGES” software: Open access tools to performQ-SARand nano-QSAR modeling. Chemom. Intell. Lab. Syst., 147 (2015) 1–13.
[26] N. Rob, Tutorial 6: Linear Regression, (2014) 1–14.
[27] D. E. Arthur, A. Uzairu, P. Mamza, S. E. Abechi, G. Shallangwa, Insilco study on the toxicity of anti-cancer compounds tested against MOLT-4 and p388 cell lines using GA-MLR technique. Beni-Suef Univ. J. Basic Appl. Sci., 5 (2016b) 320–333.
[28] A. Beheshti, E. Pourbasheer, M. Nekoei, S. Vahdani, Q-SAR modeling of antimalarial activity of urea derivatives using genetic algorithm–multiple linear regressions. J. Saudi Chem. Soc., 20 (2016) 282–290.
[29] T. I. Netzeva, A. P. Worth, T. Aldenberg, R. Benigni, M. T. Cronin, P. Gramatica, J. S. Jaworska, S. Kahn, G. Klopman, C. A. Marchant, Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships, ATLA, 33 (2005) 155–173.
[30] S. Dimitrov, G. Dimitrova, T. Pavlov, N. Dimitrova, G. Patlewicz, J. Niemela, O. Mekenyan, A stepwise approach for defining the applicability domain of SAR and Q-SAR models, J. Chem. Inf. Model. 45 (2005) 839–849.
[31] S. Alimohammadi, A. Hamidi, P. Pargolghasemi, N. Nourani, and M. S. Hoseininezhad-Namin, QSAR study of antiproliferative drug against A549 by GA-MLR and SW-MLR methods. Chemical Review and Letters, 2(4) (2019)193-198.
[32] A. Golbraikh, A. Tropsha, Beware of q2! J. Mol. Graph. Model, 20(4) (2002) 269–276.